These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 12350457)

  • 1. Brave new world of tobacco disease prevention: promoting dual tobacco-product use?
    Henningfield JE; Rose CA; Giovino GA
    Am J Prev Med; 2002 Oct; 23(3):226-8. PubMed ID: 12350457
    [No Abstract]   [Full Text] [Related]  

  • 2. Tobacco use harm reduction, elimination, and escalation in a large military cohort.
    Klesges RC; Sherrill-Mittleman D; Ebbert JO; Talcott GW; Debon M
    Am J Public Health; 2010 Dec; 100(12):2487-92. PubMed ID: 21068420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction?
    Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL
    Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response to the 2002, vol 23, issue 3 article entitled snuff use and smoking in US men: implications for harm reduction.
    Ross G
    Am J Prev Med; 2003 Apr; 24(3):285; author reply 285-6. PubMed ID: 12657350
    [No Abstract]   [Full Text] [Related]  

  • 5. Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.
    Kozlowski LT; Abrams DB
    BMC Public Health; 2016 May; 16():432. PubMed ID: 27221096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Case for Requiring Graphic Warning Labels on Smokeless Tobacco Product Packages.
    Pakhale S; Samet J; Folan P; Leone F; White A;
    Ann Am Thorac Soc; 2016 Mar; 13(3):329-33. PubMed ID: 26784741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Snus use in the U.S.: reducing harm or creating it?
    Twombly R
    J Natl Cancer Inst; 2010 Oct; 102(19):1454-6. PubMed ID: 20870974
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.
    Kozlowski LT
    Am J Prev Med; 2007 Dec; 33(6 Suppl):S379-86. PubMed ID: 18021913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is smokeless tobacco use an appropriate public health strategy for reducing societal harm from cigarette smoking?
    Tomar SL; Fox BJ; Severson HH
    Int J Environ Res Public Health; 2009 Jan; 6(1):10-24. PubMed ID: 19440266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tobacco harm reduction: thinking the unthinkable.
    Lawson E
    Br J Gen Pract; 2012 Jun; 62(599):314. PubMed ID: 22687217
    [No Abstract]   [Full Text] [Related]  

  • 11. Tobacco prevention and cessation in pediatric patients.
    Klein JD; Camenga DR
    Pediatr Rev; 2004 Jan; 25(1):17-26. PubMed ID: 14702518
    [No Abstract]   [Full Text] [Related]  

  • 12. Smokeless tobacco: the epidemiology and politics of harm.
    Phillips CV; Heavner KK
    Biomarkers; 2009 Jul; 14 Suppl 1():79-84. PubMed ID: 19604065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of epidemiologic data on the debate over smokeless tobacco's role in harm reduction.
    Timberlake DS; Zell JA
    BMC Med; 2009 Oct; 7():61. PubMed ID: 19840371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association.
    Piano MR; Benowitz NL; Fitzgerald GA; Corbridge S; Heath J; Hahn E; Pechacek TF; Howard G;
    Circulation; 2010 Oct; 122(15):1520-44. PubMed ID: 20837898
    [No Abstract]   [Full Text] [Related]  

  • 15. Smokeless tobacco as a nicotine delivery device: harm or harm reduction?
    Benowitz NL
    Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cigarette smoking cessation attempts among current US smokers who also use smokeless tobacco.
    Messer K; Vijayaraghavan M; White MM; Shi Y; Chang C; Conway KP; Hartman A; Schroeder MJ; Compton WM; Pierce JP
    Addict Behav; 2015 Dec; 51():113-9. PubMed ID: 26253939
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US.
    Zeller M; Hatsukami D;
    Tob Control; 2009 Aug; 18(4):324-32. PubMed ID: 19240228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Misleading conclusions from Altria researchers about population health effects of dual use.
    Glantz SA; Ling PM
    Nicotine Tob Res; 2011 Apr; 13(4):296; author reply 297. PubMed ID: 21350043
    [No Abstract]   [Full Text] [Related]  

  • 19. Regulating E-cigarettes: a rule proposed by the FDA aims to extend authority to E-cigarettes, other tobacco products.
    Printz C
    Cancer; 2014 Jul; 120(14):2069-71. PubMed ID: 24985247
    [No Abstract]   [Full Text] [Related]  

  • 20. National Institutes of Health State-of-the-Science conference statement: tobacco use: prevention, cessation, and control.
    NIH State-of-the-Science Panel
    Ann Intern Med; 2006 Dec; 145(11):839-44. PubMed ID: 16954353
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.